121 related articles for article (PubMed ID: 15742452)
1. Fracture prevalence and treatment with bone-sparing agents: are there urban-rural differences? A population based study in Ontario, Canada.
Cadarette SM; Jaglal SB; Hawker GA
J Rheumatol; 2005 Mar; 32(3):550-8. PubMed ID: 15742452
[TBL] [Abstract][Full Text] [Related]
2. Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?
Jaglal SB; Weller I; Mamdani M; Hawker G; Kreder H; Jaakkimainen L; Adachi JD
J Bone Miner Res; 2005 Jun; 20(6):898-905. PubMed ID: 15883628
[TBL] [Abstract][Full Text] [Related]
3. Low calcaneal bone mineral density and the risk of distal forearm fracture in women and men: a population-based case-control study.
Atroshi I; Ahlander F; Billsten M; Ahlborg HG; Mellström D; Ohlsson C; Ljunggren O; Karlsson MK
Bone; 2009 Oct; 45(4):789-93. PubMed ID: 19539795
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen use and osteoporotic fracture risk: a population-based analysis.
Cooke AL; Metge C; Lix L; Prior HJ; Leslie WD
J Clin Oncol; 2008 Nov; 26(32):5227-32. PubMed ID: 18838712
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
Teschemaker A; Lee E; Xue Z; Wutoh AK
Am J Geriatr Pharmacother; 2008 Dec; 6(5):240-8. PubMed ID: 19161926
[TBL] [Abstract][Full Text] [Related]
6. Higher bone mineral density in rural compared with urban dwellers: the NOREPOS study.
Meyer HE; Berntsen GK; Søgaard AJ; Langhammer A; Schei B; Fønnebø V; Forsmo S; Tell GS;
Am J Epidemiol; 2004 Dec; 160(11):1039-46. PubMed ID: 15561983
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
[TBL] [Abstract][Full Text] [Related]
8. Secondary prevention of osteoporosis post minimal trauma fracture in an Australian regional and rural population.
Barrack CM; McGirr EE; Fuller JD; Foster NM; Ewald DP
Aust J Rural Health; 2009 Dec; 17(6):310-5. PubMed ID: 19930197
[TBL] [Abstract][Full Text] [Related]
9. Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study.
van den Boogaard CH; Breekveldt-Postma NS; Borggreve SE; Goettsch WG; Herings RM
Curr Med Res Opin; 2006 Sep; 22(9):1757-64. PubMed ID: 16968579
[TBL] [Abstract][Full Text] [Related]
10. Gender and osteoporosis: similarities and sex-specific differences.
Boling EP
J Gend Specif Med; 2001; 4(2):36-43. PubMed ID: 11480096
[TBL] [Abstract][Full Text] [Related]
11. Investigation and treatment of osteoporosis in patients with fragility fractures.
Hajcsar EE; Hawker G; Bogoch ER
CMAJ; 2000 Oct; 163(7):819-22. PubMed ID: 11033708
[TBL] [Abstract][Full Text] [Related]
12. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.
Hanley DA; Zhang Q; Meilleur MC; Mavros P; Sen SS
Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742
[TBL] [Abstract][Full Text] [Related]
13. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
Adachi JD; Hanley DA; Lorraine JK; Yu M
Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
[TBL] [Abstract][Full Text] [Related]
14. Comparative fracture risk in vegetarians and nonvegetarians in EPIC-Oxford.
Appleby P; Roddam A; Allen N; Key T
Eur J Clin Nutr; 2007 Dec; 61(12):1400-6. PubMed ID: 17299475
[TBL] [Abstract][Full Text] [Related]
15. Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture.
Talbot JC; Elener C; Praveen P; Shaw DL
Injury; 2007 Nov; 38(11):1236-40. PubMed ID: 17572417
[TBL] [Abstract][Full Text] [Related]
16. Undertreatment of osteoporosis in regional Western Australia.
Lai MM; Ang WM; McGuiness M; Larke AB
Australas J Ageing; 2012 Jun; 31(2):110-4. PubMed ID: 22676170
[TBL] [Abstract][Full Text] [Related]
17. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of osteoporotic fractures in patients treated by androgen blockade for prostate cancer].
Dahmani L; Wagner B; Auzanneau C; Irani J; Doré B
Prog Urol; 2003 Feb; 13(1):73-8. PubMed ID: 12703357
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of vitamin D inadequacy in Belfast following fragility fracture.
Beringer T; Heyburn G; Finch M; McNally C; McQuilken M; Duncan M; Dixon T
Curr Med Res Opin; 2006 Jan; 22(1):101-5. PubMed ID: 16393436
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London.
Moniz C; Dew T; Dixon T
Curr Med Res Opin; 2005 Dec; 21(12):1891-4. PubMed ID: 16368037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
